Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Asthma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 260.6 million diagnosed prevalent cases of Asthma across 16 pharmaceutical markets. GSK is a key player in the disease space with four key products for asthma. Other main players include AstraZeneca, with two products, ... Read More
-
Global Red Biotechnology Market - 2022-2029
... 5.2% during the forecast period (2022-2029). Red biotechnology indicates biopharmaceuticals. It involves the use of biotechnology in the medical field. It covers applications of biotechnology relating to clinical trials, vaccine development, disease research, antibiotic production, ... Read More
-
Pediatric Clinical Trials Market, by Clinical Trial Phase (Pre-clinical, Phase I, Phase II, and Phase III), by Study Design (Treatment Studies and Observational Studies), by Medical Condition (Neuropsychiatric Conditions, Infectious Diseases, Maternal and Perinatal Conditions, Respiratory Diseases, Cardiovascular Diseases, Cancer, Digestive Diseases and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Respiratory Diseases, Cardiovascular Diseases, Cancer, Digestive Diseases and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Pediatric clinical trials ... Read More
-
Clinical Trials - The Movement Towards Decentralized Clinical Trials
... is the top virtual component used Scope The clinical trial data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The report focuses on DCT trials that were initiated between 2001 to 2022. ... Read More
-
North America Pharma ADMET Testing Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Testing Type (In Vivo ADMET Testing, In Vitro ADMET Testing, and In Silico ADMET Testing), Technology (Cell Culture, High Throughput, Molecular Imaging, and OMICS Technology), and Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Others)
... High Throughput, Molecular Imaging, and OMICS Technology), and Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Others) The pharma ADMET testing market in North America is expected to grow from US$ 2,998.33 million in 2022 ... Read More
-
Middle East & Africa Pharma ADMET Testing Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Testing Type (In Vivo ADMET Testing, In Vitro ADMET Testing, and In Silico ADMET Testing), Technology (Cell Culture, High Throughput, Molecular Imaging, and OMICS Technology), and Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Others)
... (Cell Culture, High Throughput, Molecular Imaging, and OMICS Technology), and Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Others) The pharma ADMET testing market in Middle East & Africa is expected to grow from US$ ... Read More
-
Pharmaceutical Drugs Industry: Global Competitive Landscape 2021
... company profiles are discussed in detail. The report also examines recent developments and product portfolios of major players, and it features market share analysis and rankings in the market. It includes a regulatory landscape analysis ... Read More
-
U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology), End User (Pharma Companies, Providers) - Forecast to 2029
... Component [Datasets (Clinical, Claims, Pharmacy), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers)- Forecast to 2029 The U.S. RWE solutions market is expected to grow at a CAGR of ... Read More
-
Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape
... be more than 36.000 diagnosed incidence cases of Autoimmune Hepatitis across 16 pharmaceutical markets. No FDA-approved marketed drugs are available for Autoimmune Hepatitis. However, there are several treatments used off-label to manage Autoimmune Hepatitis. Among ... Read More
-
AI-based Clinical Trial Solutions For Patient Matching Market Size, Share & Trends Analysis Report By Therapeutic Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030
... Growth & Trends The global AI-based clinical trial solutions for patient matching market size is expected to reach USD 1.9 billion by 2030, registering a compound annual growth rate (CAGR) of 26.7% during the forecast ... Read More
-
Global Clinical Trial Management Systems (CTMS) Market 2022 - Snapshot
... reach ~USD 2,035 million by 2028, according to a new report by Gen Consulting Company. This industry report offers market estimates of the global market, followed by a detailed analysis of the product, deployment mode, ... Read More
-
Global Clinical Trial Imaging Market - Industry Trends and Forecast to 2029
... The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029 Market Segmentation Global Clinical Trial Imaging Market, By Product ... Read More
-
Global Clinical Trial Outsourcing Market By Clinical Trial Phase (Phase 0, Phase 1, Phase 2, Phase 3, Phase 4), By Therapeutic Area (Oncology, Hematology, Central Nervous System, Cardiovascular/Metabolic, Respiratory, Infectious Diseases, Immunology, Rare Diseases, Medical Devices, Others), By End User (Biotechnology & Pharmaceutical Companies, Medical Device Companies, Academic & Research Institutions) and By Region, Competition Forecast and Opportunities, 2027
... Devices, Others), By End User (Biotechnology & Pharmaceutical Companies, Medical Device Companies, Academic & Research Institutions) and By Region, Competition Forecast and Opportunities, 2027 Global clinical trial outsourcing market is anticipated to register robust growth ... Read More
-
Europe Clinical Trial Imaging Market - Industry Trends and Forecast to 2029
... new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029 Market Segmentation Europe Clinical Trial Imaging Market, By Product & ... Read More
-
MEA Clinical Trial Imaging Market - Industry Trends and Forecast to 2029
... to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029 Market Segmentation Middle East and Africa Clinical ... Read More
-
APAC Clinical Trial Imaging Market - Industry Trends and Forecast to 2029
... new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029 Market Segmentation Asia-Pacific Clinical Trial Imaging Market, By Product & ... Read More
-
NA Clinical Trial Imaging Market - Industry Trends and Forecast to 2029
... The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029 Market Segmentation North America Clinical Trial Imaging Market, By ... Read More
-
Rare Kidney Disorders Market, 2022-2035
... cases / individuals in the US and Europe. Despite their relatively low prevalence, these set of indications are believed to be one of the leading causes of renal diseases, along with diabetes and other rare ... Read More
-
Global Undifferentiated Pleomorphic Sarcoma Therapeutics Market - 2022-2029
... at a CAGR of XX % during the forecast period (2022-2029). Soft tissue cancers include malignant fibrous histiocytoma, often undifferentiated pleomorphic sarcoma. It's rare cancer that frequently metastasizes to other body regions and returns after ... Read More
-
Primary Biliary Cholangitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... there will be more than 500,000 diagnosed prevalent cases of PBC across 16 pharmaceutical markets. There are three leading marketed products for the treatment of PBC, Intercept Pharmaceuticals is a key player in the disease ... Read More
-
Phenylketonuria Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 500,000 diagnosed prevalent cases of PKU across 16 pharmaceutical markets. There are only two leading marketed drugs for the treatment of PKU, both from BioMarin Pharmaceutical. R&D activity in PKU is relatively low, with ... Read More
-
Crohn’s Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis
... (IBD) that causes digestive tract inflammation, leading to abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition. The inflammatory bowel disease treatment market can be segmented into two types, i.e., Crohn's Disease and Ulcerative Colitis. ... Read More
-
Peripheral T-Cell Lymphomas (PTCL) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Peripheral T-Cell Lymphomas (PTCL) Clinical trials scenario. This report provides top line data ... Read More
-
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer ... Read More
-
Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Systemic Sclerosis (Scleroderma) Clinical trials scenario. This report provides top line data relating to the ... Read More
Research Assistance
